Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P02749 (
beta2-glycoprotein I
)
836
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Apoptosis (programmed cell death) is accompanied by loss of phospholipid asymmetry, i.e., translocation of aminophospholipids such as phosphatidylserine to the outer leaflet of the plasma membranes, which results in recognition of these cells by macrophages. In the present study, I studied on the involvement of
beta 2-glycoprotein I
(
beta 2-GPI
) and anti-
beta 2-GPI
antibodies in apoptotic lymphocytes. By flowcytometric analysis, I demonstrated that
beta 2-GPI
could bind to a human T cell line, Jurkat cells, treated with an anti-
Fas
antibody, CH11.
beta 2-GPI
-bound cells were detected 2 hr later after anti-
Fas
treatment and the most cells were bound to
beta 2-GPI
by 6 hr later. The accumulation of
beta 2-GPI
-bound cells paralleled with morphological changes and DNA fragmentation of the cells. I also demonstrated that anti-
beta 2-GPI
antibodies and a
beta 2-GPI
-dependent anti-cardiolipin antibody, established from a patient with antiphospholipid syndrome, could recognize
beta 2-GPI
-bound Jurkat cells treated with anti-
Fas
-antibody. These results imply that
beta 2-GPI
and anticardiolipin antibody may have a role in the clearance of apoptotic cells from the blood stream.
...
PMID:[Investigation of binding capacity of beta 2-glycoprotein I with anti-beta 2-glycoprotein I antibodies in lymphocytes undergoing apoptosis]. 1073 59